Source disclosure: February 20, 2026
Astena Holdings Co.,Ltd. [8095.T]
TOKYO, Feb 20 (Pulse News Wire) -- Astena Holdings Co., Ltd. (8095.T), represented by Chairman and CEO Satoshi Setoguchi, announced today that it has received dividends totaling ¥458 million from its wholly-owned subsidiary Spera Pharma Co., Ltd. The dividend resolution was made on February 20, 2026, during a shareholders' meeting held within the subsidiary company. The actual transfer of funds is scheduled for February 24, 2026.
The dividend payment will be reflected as operating revenue in Astena Holdings' individual financial statements for the fiscal year ending November 2026. However, since this dividend comes from a consolidated subsidiary, it will not impact the company's overall consolidated earnings for the same period.
AI-translated content. 🟡 Confidence: Standard See terms • Original filing